{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:49:59Z","timestamp":1779328199715,"version":"3.51.4"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-021-00492-7","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T10:09:03Z","timestamp":1628676543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Simulated trials: in silico approach adds depth and nuance to the RCT gold-standard"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-1762","authenticated-orcid":false,"given":"Leia","family":"Wedlund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-2291","authenticated-orcid":false,"given":"Joseph","family":"Kvedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"492_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/09500790108666984","volume":"15","author":"K Morrison","year":"2001","unstructured":"Morrison, K. Randomised controlled trials for evidence-based education: some problems in judging\u2019what works\u2019. Eval. Res. Educ. 15, 69\u201383 (2001).","journal-title":"Eval. Res. Educ."},{"key":"492_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jvs.2009.01.012","volume":"50","author":"AW Hoel","year":"2009","unstructured":"Hoel, A. W. et al. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J. Vasc. Surg. 50, 349\u2013354 (2009).","journal-title":"J. Vasc. Surg."},{"key":"492_CR3","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","volume":"162","author":"A Heiat","year":"2002","unstructured":"Heiat, A., Gross, C. P. & Krumholz, H. M. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch. Intern. Med. 162, 1682\u20131688 (2002).","journal-title":"Arch. Intern. Med."},{"key":"492_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-021-00452-1","volume":"4","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimeras disease. NPJ Digital Med. 4, 1\u20139 (2021).","journal-title":"NPJ Digital Med."},{"key":"492_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000338236","volume":"33","author":"RS Doody","year":"2012","unstructured":"Doody, R. S. et al. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer\u2019s disease: a subgroup analysis in patients already taking or not taking concomitant memantine. Dementia Geriatric Cognit. Disord. 33, 164\u2013173 (2012).","journal-title":"Dementia Geriatric Cognit. Disord."},{"key":"492_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jagp.2014.09.007","volume":"23","author":"JR Tinklenberg","year":"2015","unstructured":"Tinklenberg, J. R. et al. Donepezil treatment in ethnically diverse patients with Alzheimer disease. Am. J. Geriatric Psychiatry 23, 384\u2013390 (2015).","journal-title":"Am. J. Geriatric Psychiatry"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00492-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T18:57:17Z","timestamp":1670093837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00492-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1038\/s41746-021-00492-7","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.K. is Editor in Chief of <i>npj Digital Medicine<\/i>. L.W. has no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}